FR2325379A1 - Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique - Google Patents

Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique

Info

Publication number
FR2325379A1
FR2325379A1 FR7529819A FR7529819A FR2325379A1 FR 2325379 A1 FR2325379 A1 FR 2325379A1 FR 7529819 A FR7529819 A FR 7529819A FR 7529819 A FR7529819 A FR 7529819A FR 2325379 A1 FR2325379 A1 FR 2325379A1
Authority
FR
France
Prior art keywords
antispasmodic
tetrahydro
hydroxyethyl
application
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7529819A
Other languages
English (en)
Other versions
FR2325379B1 (fr
Inventor
Roland Yves Mauvernay
Norbert Busch
Jacques Moleyre
Jacques Simond
Andre Monteil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Europeen de Recherches Mauvernay CERM
Original Assignee
Centre Europeen de Recherches Mauvernay CERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Europeen de Recherches Mauvernay CERM filed Critical Centre Europeen de Recherches Mauvernay CERM
Priority to FR7529819A priority Critical patent/FR2325379A1/fr
Priority to BE170172A priority patent/BE845629A/fr
Priority to CH1160676A priority patent/CH614436A5/xx
Priority to US05/724,068 priority patent/US4062956A/en
Priority to AU17866/76A priority patent/AU498800B2/en
Priority to DE19762642930 priority patent/DE2642930A1/de
Priority to CA261,986A priority patent/CA1070689A/fr
Priority to ES451918A priority patent/ES451918A1/es
Priority to GB40204/76A priority patent/GB1535830A/en
Priority to JP51116474A priority patent/JPS5262284A/ja
Priority to NL7610742A priority patent/NL7610742A/xx
Publication of FR2325379A1 publication Critical patent/FR2325379A1/fr
Application granted granted Critical
Publication of FR2325379B1 publication Critical patent/FR2325379B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7529819A 1975-09-29 1975-09-29 Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique Granted FR2325379A1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR7529819A FR2325379A1 (fr) 1975-09-29 1975-09-29 Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique
BE170172A BE845629A (fr) 1975-09-29 1976-08-27 Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodiques
CH1160676A CH614436A5 (fr) 1975-09-29 1976-09-13
US05/724,068 US4062956A (en) 1975-09-29 1976-09-16 Substituted 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines and quaternary salts thereof useful for treating spasmodic syndromes
AU17866/76A AU498800B2 (en) 1975-09-29 1976-09-17 2-2(-hydroxyethyl) tetrahydro-1,4 oxazines
CA261,986A CA1070689A (fr) 1975-09-29 1976-09-24 2-(2-hydroxyethyl) tetrahydro-1,4 oxazines et leurs sels quaternaires aidant a traiter les spasmes
DE19762642930 DE2642930A1 (de) 1975-09-29 1976-09-24 Substituierte 2-(2-hydroxyaethyl) tetrahydro-1,4-oxazine, ihre quaternaeren derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
ES451918A ES451918A1 (es) 1975-09-29 1976-09-28 Procedimiento para preparar 2-(2-hidroxietil)-tetrahidro-1, 4-oxazinas sustituidas.
GB40204/76A GB1535830A (en) 1975-09-29 1976-09-28 Oxazine derivatives
JP51116474A JPS5262284A (en) 1975-09-29 1976-09-28 Substituted 22*22hydroxyethyl* tetrahydroo1*4 oxazine quarternary derivatives and their preparation
NL7610742A NL7610742A (nl) 1975-09-29 1976-09-28 Gesubstitueerde 2-(2-hydroxyethyl)tetrahydro-1. 4-oxazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7529819A FR2325379A1 (fr) 1975-09-29 1975-09-29 Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique

Publications (2)

Publication Number Publication Date
FR2325379A1 true FR2325379A1 (fr) 1977-04-22
FR2325379B1 FR2325379B1 (fr) 1979-01-12

Family

ID=9160603

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7529819A Granted FR2325379A1 (fr) 1975-09-29 1975-09-29 Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique

Country Status (11)

Country Link
US (1) US4062956A (fr)
JP (1) JPS5262284A (fr)
AU (1) AU498800B2 (fr)
BE (1) BE845629A (fr)
CA (1) CA1070689A (fr)
CH (1) CH614436A5 (fr)
DE (1) DE2642930A1 (fr)
ES (1) ES451918A1 (fr)
FR (1) FR2325379A1 (fr)
GB (1) GB1535830A (fr)
NL (1) NL7610742A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604031B2 (en) 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH471146A (de) * 1966-03-16 1969-04-15 Geigy Ag J R Verfahren zur Herstellung von neuen Morpholinderivaten

Also Published As

Publication number Publication date
ES451918A1 (es) 1977-08-16
DE2642930A1 (de) 1977-03-31
AU498800B2 (en) 1979-03-22
GB1535830A (en) 1978-12-13
NL7610742A (nl) 1977-03-31
CH614436A5 (fr) 1979-11-30
US4062956A (en) 1977-12-13
CA1070689A (fr) 1980-01-29
JPS5262284A (en) 1977-05-23
AU1786676A (en) 1978-03-23
FR2325379B1 (fr) 1979-01-12
BE845629A (fr) 1977-02-28

Similar Documents

Publication Publication Date Title
BE838509A (fr) Nouveaux derives de l'isoxazole, leur preparation et leur application comme medicaments
FR2336135A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
BE869133A (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2333504A1 (fr) Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
BE839967R (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
FR2339598A1 (fr) Nouveaux derives de la pyrrolidine, leur preparation et leur application comme medicaments
FR2341577A1 (fr) Nouveaux derives de la piperazine, leur preparation et leur application comme medicaments
FR2320090A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2316949A1 (fr) Derives du benzo-cyclohepta-thiophene, leur preparation et leur application comme medicaments
FR2325379A1 (fr) Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique
BE848936A (fr) Nouveaux derives du 3-aza-bicyclo(3.1.0)hexane, leur preparation et leur application comme medicaments
FR2316939A1 (fr) Derives de 2-benzopyranone et leur application comme medicaments
BE839969A (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
FR2335225A1 (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
BE865267A (fr) Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments
FR2320103A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2323386A1 (fr) Nouveaux derives de la benzo-cyclohepta-pyridine, leur preparation et leur application comme medicaments
FR2322594A1 (fr) Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments
BE843039A (fr) Nouveaux derives de benzo-cyclochepta-thiophene, leur preparation et leur application comme medicaments
FR2300564A1 (fr) Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
FR2302090A1 (fr) Nouveaux derives de l'indoline, leur preparation et leur application comme medicaments
FR2321287A1 (fr) Nouveaux derives du 2,1,3-benzothiadiazole, leur preparation et leur application comme medicaments
BE838460A (fr) Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
BE849406A (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
FR2303540A1 (fr) Nouveaux derives de la benzofurannone, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse